Henan Lingrui Pharmaceutical Co Ltd (600285) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Henan Lingrui Pharmaceutical Co Ltd (600285) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥140.12 Million ≈ $20.50 Million USD) by net assets (CN¥3.28 Billion ≈ $480.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Henan Lingrui Pharmaceutical Co Ltd (600285) market capitalisation for the company's overall valuation and market capitalisation.

Henan Lingrui Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Henan Lingrui Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Lingrui Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 600285 cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
HBIS Resources Co Ltd
SHE:000923
0.010x
Changchun UP Optotech Co Ltd
SHE:002338
-0.016x
Jiangsu Expressway Company Limited
F:JE2
0.035x
Suning Commerce Group Co Ltd
SHE:002024
0.015x
Siloam International Hospitals
JK:SILO
0.027x
Kernel Holding SA
WAR:KER
-0.080x
Shinkong Insurance Co Ltd
TW:2850
0.144x
Kansai Nerolac Paints Limited
NSE:KANSAINER
0.031x

Annual Cash Flow Conversion Efficiency for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. View 600285 stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.44 Billion
≈ $502.78 Million
CN¥553.88 Million
≈ $81.05 Million
0.161x -43.31%
2024-12-31 CN¥3.08 Billion
≈ $450.74 Million
CN¥875.86 Million
≈ $128.17 Million
0.284x -2.17%
2023-12-31 CN¥2.80 Billion
≈ $409.54 Million
CN¥813.43 Million
≈ $119.03 Million
0.291x -10.94%
2022-12-31 CN¥2.56 Billion
≈ $374.38 Million
CN¥834.91 Million
≈ $122.17 Million
0.326x -11.77%
2021-12-31 CN¥2.29 Billion
≈ $334.60 Million
CN¥845.69 Million
≈ $123.75 Million
0.370x +90.63%
2020-12-31 CN¥2.32 Billion
≈ $339.80 Million
CN¥450.53 Million
≈ $65.93 Million
0.194x -4.30%
2019-12-31 CN¥2.22 Billion
≈ $324.92 Million
CN¥450.15 Million
≈ $65.87 Million
0.203x -2.67%
2018-12-31 CN¥2.09 Billion
≈ $306.49 Million
CN¥436.25 Million
≈ $63.84 Million
0.208x +333.20%
2017-12-31 CN¥2.20 Billion
≈ $322.52 Million
CN¥105.97 Million
≈ $15.51 Million
0.048x +60.53%
2016-12-31 CN¥2.11 Billion
≈ $309.08 Million
CN¥63.26 Million
≈ $9.26 Million
0.030x -67.07%
2015-12-31 CN¥1.72 Billion
≈ $252.28 Million
CN¥156.82 Million
≈ $22.95 Million
0.091x +14.19%
2014-12-31 CN¥1.56 Billion
≈ $228.39 Million
CN¥124.32 Million
≈ $18.19 Million
0.080x -38.36%
2013-12-31 CN¥984.89 Million
≈ $144.12 Million
CN¥127.27 Million
≈ $18.62 Million
0.129x +483.53%
2012-12-31 CN¥696.97 Million
≈ $101.99 Million
CN¥15.43 Million
≈ $2.26 Million
0.022x -62.59%
2011-12-31 CN¥684.01 Million
≈ $100.09 Million
CN¥40.49 Million
≈ $5.92 Million
0.059x +1163.14%
2010-12-31 CN¥709.69 Million
≈ $103.85 Million
CN¥-3.95 Million
≈ $-578.20K
-0.006x -102.71%
2009-12-31 CN¥645.69 Million
≈ $94.48 Million
CN¥132.61 Million
≈ $19.40 Million
0.205x +158.23%
2008-12-31 CN¥549.72 Million
≈ $80.44 Million
CN¥43.72 Million
≈ $6.40 Million
0.080x +188.20%
2007-12-31 CN¥579.24 Million
≈ $84.76 Million
CN¥15.99 Million
≈ $2.34 Million
0.028x -49.82%
2006-12-31 CN¥486.67 Million
≈ $71.21 Million
CN¥26.76 Million
≈ $3.92 Million
0.055x -21.07%
2005-12-31 CN¥479.80 Million
≈ $70.21 Million
CN¥33.43 Million
≈ $4.89 Million
0.070x -7.89%
2004-12-31 CN¥469.45 Million
≈ $68.70 Million
CN¥35.51 Million
≈ $5.20 Million
0.076x +43.63%
2003-12-31 CN¥451.69 Million
≈ $66.10 Million
CN¥23.79 Million
≈ $3.48 Million
0.053x -68.38%
2002-12-31 CN¥416.74 Million
≈ $60.98 Million
CN¥69.41 Million
≈ $10.16 Million
0.167x +1861.90%
2001-12-31 CN¥401.79 Million
≈ $58.79 Million
CN¥3.41 Million
≈ $499.14K
0.008x -5.34%
2000-12-31 CN¥408.46 Million
≈ $59.77 Million
CN¥3.66 Million
≈ $536.06K
0.009x -88.42%
1999-12-31 CN¥62.08 Million
≈ $9.08 Million
CN¥4.81 Million
≈ $703.65K
0.077x --

About Henan Lingrui Pharmaceutical Co Ltd

SHG:600285 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.59 Billion
CN¥10.83 Billion CNY
Market Cap Rank
#7095 Global
#1528 in China
Share Price
CN¥19.10
Change (1 day)
-0.10%
52-Week Range
CN¥19.03 - CN¥23.48
All Time High
CN¥26.75
About

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orth… Read more